Advertisement

Brain Tumors

  • Saverio Pollice
  • Gilda Morlino
  • Michela Capuano
  • Tommaso Scarabino

Abstract

Primary central nervous system (CNS) tumors have an incidence ranging from 5 to 17 cases per 100,000 inhabitants per year, with no significant differences between nations. They cause 2–5% of all cancer deaths [1]. In Italy, the annual incidence of new brain tumors ranges from 8.4 to 9.2 per 100,000 per year.

Keywords

Brain Tumor Karnofsky Performance Status Anaplastic Astrocytoma Astrocytic Tumor Acoustic Neuroma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Moller-Jensen O, Esteve J, Moller H et al (1990) Cancer in the European Community and its member States. Eur J Cancer 26:1167-1256CrossRefGoogle Scholar
  2. 2.
    Werner MH, Phuphanich S, Lyman GH (1995) The increasing incidence of malignant gliomas and primary central nervous system lynphoma in the elderly. Cancer 76:1634-1642PubMedCrossRefGoogle Scholar
  3. 3.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) World Health Organization classification of tumours of the central nervous system. IARC, LyonGoogle Scholar
  4. 4.
    Kleihues P, Cavenee WK eds (2000) Pathology and genetics of tumours of the nervous system, World Health Organization classification of tumours. IARC, LyonGoogle Scholar
  5. 5.
    Brandes AA, Reni M, Carapella C et al (2009) Linee guida in neuro-oncologia a cura dell’AIOM, pp 357-392Google Scholar
  6. 6.
    Walter AW, Hancock ML, Pui CH et al (1998) Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children’s Research Hospital. J Clin Oncol 16:3761-3767PubMedGoogle Scholar
  7. 7.
    Salvatore JR, Weitberg AB, Mehta S (1996) Nonionizing electromagnetic fields and cancer: a review. Oncology 10:563-574PubMedGoogle Scholar
  8. 8.
    Kaplan S, Novikov I, Modan B (1997) Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol. Am J Epidemiol 146:832-841PubMedGoogle Scholar
  9. 9.
    Inskip PD, Mellemkjaer L, Gridley G et al (1998) Incidence of intracranial tumors following hospitalization for head injuries. Cancer Causes Control 9:109-116PubMedCrossRefGoogle Scholar
  10. 10.
    Rice JM, Wilbourn JD (2000) Tumors of the nervous system in carcinogenic hazard identification. Toxicol Pathol 28:202-214PubMedCrossRefGoogle Scholar
  11. 11.
    Cordier S, Monfort C, Filippini G et al (2004) Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: The SEARCH International Childhood Brain Tumor Study. Am J Epidemiol 159:1109-1116PubMedCrossRefGoogle Scholar
  12. 12.
    Inskip PD, Tarone RE, Hatch EE et al (2001) Cellular-telephone use and brain tumors. N Engl J Med 344:79-86PubMedCrossRefGoogle Scholar
  13. 13.
    Hardell L, Carlberg M, Soderqvistn F et al (2008) Metaanalysis of long-term mobile phone use and the association with brain tumours. Int J Oncol 32:1097-1103PubMedGoogle Scholar
  14. 14.
    DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114-123PubMedCrossRefGoogle Scholar
  15. 15.
    Kleihues P et al (2000) Glioblastoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system, World Health Organization classification of tumours. IARC, LyonGoogle Scholar
  16. 16.
    Kleihues P, Burger PC, Aldape KD et al (2007) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) World Health Organization classification of tumours of the central nervous system. IARC, LyonGoogle Scholar
  17. 17.
    Van den Bent MJ, Looijenga LH, Langenberg K et al (2003) Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 97:1276-1284PubMedCrossRefGoogle Scholar
  18. 18.
    Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 532:997-1003CrossRefGoogle Scholar
  19. 19.
    Parsons DW, Sian J, Zhang X et al (2008) An integrating genomic analysis of human glioblastoma multiforme. Science 321:1807-1812PubMedCrossRefGoogle Scholar
  20. 20.
    Yan H, Parson DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773PubMedCrossRefGoogle Scholar
  21. 21.
    Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445-1453PubMedCrossRefGoogle Scholar
  22. 22.
    Curran WJ, Scott CB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704-710PubMedCrossRefGoogle Scholar
  23. 23.
    Mirimanoff RO, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORT 26981/122981 – NCIC CE 3 phase III randomized trial. J Clin Oncol 24:2563-2569PubMedCrossRefGoogle Scholar
  24. 24.
    Doyle WK, Budinger TF, Valk PE et al (1987) Differentiation of cerebral radiation necrosis from tumor recurrence by (18)FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11:563-570PubMedCrossRefGoogle Scholar
  25. 25.
    Langleben DD, Segal GM (2000) PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41:1861-1867PubMedGoogle Scholar
  26. 26.
    DeAngelis LM, Loeffler JS, Adam N et al (2007) Primary and metastatic brain tumors. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD (eds) Cancer management: a multidisciplinary approach, 10th edn. CMPMedica, New YorkGoogle Scholar
  27. 27.
    Chang SM, Parney IF, Huang W et al (2005) Glioma Outcomes Project Investigators. Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-564Google Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Saverio Pollice
    • 1
  • Gilda Morlino
  • Michela Capuano
  • Tommaso Scarabino
  1. 1.Department of Radiology“L. Bonomo” HospitalItaly

Personalised recommendations